Japan
Longi’s actions against JinkoSolar are the latest in a growing number of patent infringement disputes involving solar technology
Partners at Anderson Mori & Tomotsune say AI and the UPC are providing new business opportunities and reveal why flexibility is key to retaining talent
Each week Managing IP speaks to a different IP practitioner about their life and career
Each week Managing IP speaks to a different IP practitioner about their life and career
Sponsored
Sponsored
-
Sponsored by Satyapon & PartnersKritsana Mingtongkhum and Shantanu Ajit Tambe of Satyapon & Partners provide a guide to claiming trademark infringement damages in Thailand, and suggest an approach that could offer quicker resolution and yield a higher amount -
Sponsored by Shiga International Patent OfficeMasato Iida of Shiga International Patent Office explains what types of bio inventions are deemed eligible for patent protection in Japan and draws comparisons with US practice
-
Sponsored by Shiga International Patent OfficeThe Japan Patent Office has published additional case examples designed to clarify the patentability of AI-related technology. Fumio Takahashi of Shiga International Patent Office explains the new guidance
-
Sponsored by Shiga International Patent OfficeMasato Iida of Shiga International Patent Office explains how the inventive step obstacle can be cleared when preparing a patent application and presents several case studies based on combination therapy inventions
-
Sponsored by Shiga International Patent OfficeHidenori Hamai of Shiga International Patent Office compares particular claim expressions at the JPO, USPTO, and EPO
-
Sponsored by ABE & PartnersTakanori Abe of Abe & Partners reports on an appellate ruling in Japan concerning the authorisation of marketing of a generic medicinal product under the patent linkage system
-
Managing IP is seeking views from in-house trademark lawyers on the changing nature of their role and what they think about it
-
With WIPO and the EPO both reporting an increase in patent filings last year, Managing IP examines the changing forces affecting global innovation
-
The Managing IP Asia Awards 2019 ceremony was held on March 20 in Hong Kong; we can now publish the winners here
-
Managing IP reveals the shortlists for the Asia-Pacific Awards 2019. The MIP Asia-Pacific Awards ceremony is on March 20 at the Island Shangri-La, Hong Kong
-
Patent Strategy’s landmark survey of more than 60 in-house lawyers shows that most businesses are still unsure about what can be patent protected and how best to apply for protection in the field of AI
-
The International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH) which commenced in 1990 made it possible to use common scientific and technical methods in drug development in Japan, the United States and EU. As a result, in approval reviews of medicinal drugs in Japan, results from foreign clinical trials are utilised based on bridging development strategy as stipulated by ICH Guideline E5.
-
The Derwent Top 100 Global Innovators report published by Clarivate Analytics details the top companies for innovation based on volume, success, globalisation and the influence of patents. It examines the jurisdictions and industry sectors with the highest levels of innovation
-
The state of standard essential patents in China, Japan and Germany, as well as challenges in patenting blockchain, were highlights from the 1st Asia-Pacific Licensing Executives Society Young Members Congress Conference
-
Managing IP’s annual survey ranks the top Patent Cooperation Treaty filers in the main patenting jurisdictions. Data compiled by CPA Global
-
The PD-1 antibody patent litigation, globally filed in Japan, the United States and Europe, came to an end with a settlement.
-
The direction of drug discovery has moved from focusing on low molecular weight compounds to biopharmaceuticals, and the percentage of biopharmaceuticals being sold is increasing. The first biosimilar patent litigation was also filed.
-
A newsletter published by Haseltine Lake reveals autonomous vehicle patent applications have soared since 2011, with Ford leading the way. It analyses applications and grants since 1999, filing jurisdictions, and the most active companies
